Irbesartan

Like other ARBs, irbesartan works by blocking the angiotensin II type 1 (AT1) receptor ^{[1, 2]}. Angiotensin II is a hormone that constricts blood vessels, stimulates aldosterone release (salt and water retention), and promotes harmful changes in the heart, blood vessels, and kidneys.

By blocking the AT1 receptor, irbesartan ^{[1, 3]}: - Lowers blood pressure by relaxing blood vessels - Reduces aldosterone secretion — decreasing salt and water retention - Protects the kidneys — angiotensin II promotes kidney damage by increasing pressure within the glomeruli (the kidney's filtering units) and promoting fibrosis and inflammation

Irbesartan's kidney-protective effects go beyond blood pressure control ^{[4, 5]}. In the IDNT (Irbesartan Diabetic Nephropathy Trial), irbesartan reduced the risk of: - Doubling of serum creatinine by 33% compared to placebo - End-stage renal disease by 23% compared to placebo - These benefits were independent of blood pressure reduction ^[4]

The IRMA-2 trial showed that irbesartan 300 mg daily reduced the progression from microalbuminuria to overt diabetic nephropathy by 70% ^[5].

Like all ARBs, irbesartan does not block bradykinin degradation, resulting in a significantly lower rate of cough compared to ACE inhibitors ^{[1, 2]}.

When starting irbesartan, the experience is very similar to other ARBs ^{[1, 2]}.

First few days: Most patients notice minimal side effects. Mild dizziness or lightheadedness may occur, particularly if you are dehydrated or on a diuretic. Stay hydrated and rise slowly from sitting or lying positions.

First 1-2 weeks: Blood pressure begins to decrease. Your doctor will likely check kidney function and potassium levels.

2-4 weeks: Full antihypertensive effect is typically achieved at a given dose.

For diabetic nephropathy: Kidney protection benefits develop over months to years of treatment. Reduction in proteinuria may be measurable within weeks, but the long-term benefit (slowing kidney disease progression) requires continuous, long-term use ^{[4, 5]}.

Overall tolerability: In clinical trials, irbesartan had a side effect profile similar to placebo ^[1]. It is one of the best-tolerated antihypertensive medications available.

Food [1]: Irbesartan can be taken with or without food. Food does not significantly affect absorption or efficacy. Take it the same way each day for consistency.

Potassium-rich foods [1, 4]: Moderate dietary potassium is fine. Avoid excessive intake and do not use potassium-containing salt substitutes without medical guidance, as irbesartan can increase potassium levels.

Alcohol [1]: Alcohol enhances the blood pressure-lowering effect. Limit to moderate consumption, especially during initial dosing.

Grapefruit: Irbesartan is metabolized primarily by CYP2C9, not CYP3A4. Grapefruit juice does not significantly affect irbesartan levels.

Hypertension [1, 2]: - Start: 150 mg once daily - May increase to 300 mg once daily if needed - Maximum: 300 mg/day - Volume-depleted patients (on diuretics): Consider starting at 75 mg once daily

Diabetic nephropathy (type 2 diabetes) [1, 4, 5]: - Target dose: 300 mg once daily - This is the dose studied in the IDNT and IRMA-2 trials that showed kidney protection - Lower doses may not provide the same degree of kidney protection - Used in patients with serum creatinine >1.5 mg/dL (men) or >1.2 mg/dL (women) and proteinuria >900 mg/day ^[4]

Renal impairment: No dose adjustment needed, but monitor potassium and creatinine closely. Use with caution in severe impairment ^[1].

Hepatic impairment: No dose adjustment needed for mild-to-moderate impairment. No data in severe impairment ^[1].

Elderly: No dose adjustment needed. Start at the recommended dose of 150 mg daily ^[1].

Generic irbesartan has been available since 2012 ^{[6, 7]}.

Pricing comparison [6, 7]: - Generic irbesartan: $10-25/month - Brand Avapro: $200-350/month (rarely prescribed) - Generic irbesartan/HCTZ combination: $15-35/month - Savings: approximately 85-95% with generic

Insurance coverage: Generic irbesartan is Tier 1-2 on most formularies ^[7].

Cost-saving tips: - Available on many discount generic programs at major pharmacies - GoodRx coupons can bring prices below $15/month - The 300 mg dose (needed for kidney protection) may cost slightly more than 150 mg — check prices - For hypertension alone (without diabetic nephropathy), losartan may be an even cheaper ARB option

Note on valsartan/irbesartan recalls [8]: Like valsartan, some generic irbesartan products were recalled in 2018-2019 due to NDMA contamination. All affected products have been removed from the market.

Pregnancy [1, 2]: Irbesartan carries a boxed warning regarding pregnancy — identical to all ARBs. Use during the second and third trimesters can cause fetal injury and death ^[1].

Discontinue immediately when pregnancy is detected. Safer alternatives include methyldopa, labetalol, and nifedipine.

Breastfeeding [1, 9]: Irbesartan is present in rat milk. It is not known whether it is excreted in human breast milk. ARBs are generally not recommended during breastfeeding due to insufficient safety data. Discuss alternatives with your doctor.

Generic irbesartan has been available since 2012 ^{[6, 7]}.

Available generic formulations: - Irbesartan tablets: 75, 150, 300 mg — equivalent to Avapro - Irbesartan/hydrochlorothiazide combination: various strengths — equivalent to Avalide - All generics are AB-rated by the FDA ^[6]

Brand vs. generic: No clinically meaningful differences in efficacy or safety.

Key advantage of irbesartan: Its high bioavailability (60-80%) is the best among ARBs, meaning a larger proportion of each dose reaches the bloodstream.